Categories
Price Data
NASDAQELOS

Overview

Syneron Medical Ltd. (NASDAQ: ELOS) is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint.

The Company’s technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring,  hair removal, wrinkle reduction, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela.  

Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US.  The company markets, services and supports its products in 86 countries.  It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

Additional information can be found at www.syneron-candela.com

September 17 Investors Meeting replay is available HERE

Download the Syneron September 17 Investors Meeting Presentation HERE

Download The UltraShape FDA Clearance Conference Call Presentation HERE

 

 

Syneron Investor Presentation August 2014
Syneron Investor Presentation August 2014 (1.7 MB)

 
Syneron Events
Wednesday, November 12, 2014
8:30am EST

Syneron management will host a conference call and a live webcast at 8:30 a.m. (ET) on November 12, 2014. A question & answer session will follow management's discussion of events in the third...

See calendar